Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer research hub
4 indexed studies · 1 currently recruiting
- active not recruitingPHASE3
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
This study looks into a new drug called elinzanetant to see if it can help women with hot flashes caused by breast cancer treatment. It compares the drug to a dummy pill to check how well it works and if it's safe.
Austria · Belgium · Canada - active not recruiting
A Study in Germany to Learn About the Value of Fezolinetant in Treating Hot Flashes and Night Sweats in Women During Menopause
This study in Germany is for women with hot flashes and night sweats during menopause who are prescribed fezolinetant. It aims to understand how well this non-hormonal tablet helps with these symptoms in real-world use.
Germany - recruiting
A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for Hot Flashes, When Given in Clinical Practice
This study looks at how a new medicine, fezolinetant, helps Canadian women in menopause with hot flashes and night sweats. It checks if the medicine improves symptoms, sleep, and overall wellbeing over 12 weeks and up to a year, as it's used in everyday care.
Canada - active not recruitingPHASE3
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
This study looks at whether fezolinetant can reduce hot flashes in women with breast cancer who are having hormone therapy. These hot flashes are a common side effect, and current treatments like HRT aren't suitable. We want to see if fezolinetant helps more than a dummy pill.
Canada · Czechia · Denmark